Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
The FDA is investigating concerns about metals in tampons after a 2024 study. The agency is conducting an internal study and re...
Barclays analyst Lauren Lieberman maintains Edgewell Personal Care (NYSE:EPC) with a Equal-Weight and lowers the price targe...
UBS analyst Peter Grom maintains Edgewell Personal Care (NYSE:EPC) with a Neutral and lowers the price target from $42 to $40.
Dan Sullivan, currently CFO and President of Europe and Latin America, has been appointed to the position of COO, effective imm...
Full Fiscal Year 2024 Financial Outlook The Company is providing the following outlook assumptions for fiscal 2024: Organi...
Full Fiscal Year 2024 Financial Outlook The Company is providing the following outlook assumptions for fiscal 2024: Org...
Edgewell Personal Care (NYSE:EPC) reported quarterly earnings of $1.22 per share which beat the analyst consensus estimate of $...
Barclays analyst Lauren Lieberman maintains Edgewell Personal Care (NYSE:EPC) with a Equal-Weight and raises the price targe...
